|
Biomarkers are defined as biological indicators of a physiological or disease process that has diagnostic and/or prognostic utility. Our ability to study and treat disease is hampered by a lack of unique, reliable, quantifiable and easily measured biomarkers that correlate well with disease progression. Signosis is a molecular tool company that is focused on developing innovative and unique products for biomarker discovery and analysis in the areas of life science research, clinical application and drug discovery. Our mission is to become a worldwide provider with a broad spectrum of more sensitive, cost-effective, rapid assay products to target biomarkers such as disease-related proteins, mRNAs, microRNAs, epigenetic variations, and SNP, with emphasis in a number of diseases including cancers, diabetes/obesity, and cardiovascular diseases.
|